Literature DB >> 24532042

Anti-ADAMTS13 IgG autoantibodies present in healthy individuals share linear epitopes with those in patients with thrombotic thrombocytopenic purpura.

Rana Grillberger1, Veronica C Casina, Peter L Turecek, X Long Zheng, Hanspeter Rottensteiner, Friedrich Scheiflinger.   

Abstract

Entities:  

Keywords:  ADAMTS13 antibodies; epitope mapping; linear epitopes; thrombotic thrombocytopenic purpura

Mesh：

Substances：

Year:  2014        PMID： 24532042      PMCID： PMC3971096          DOI： 10.3324/haematol.2013.100685

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  19 in total

1.  Multiple domains of ADAMTS13 are targeted by autoantibodies against ADAMTS13 in patients with acquired idiopathic thrombotic thrombocytopenic purpura.

Authors:  X Long Zheng; Haifeng M Wu; Dezhi Shang; Erica Falls; Christopher G Skipwith; Spero R Cataland; Charles L Bennett; Hau C Kwaan
Journal:  Haematologica       Date:  2010-04-07       Impact factor: 9.941

2.  Epitope analysis of autoantibodies to ADAMTS13 in patients with acquired thrombotic thrombocytopenic purpura.

Authors:  Yusuke Yamaguchi; Takanori Moriki; Atsuko Igari; Terumichi Nakagawa; Hideo Wada; Masanori Matsumoto; Yoshihiro Fujimura; Mitsuru Murata
Journal:  Thromb Res       Date:  2011-04-14       Impact factor: 3.944

3.  Identification of ADAMTS13 peptide sequences binding to von Willebrand factor.

Authors:  Takanori Moriki; Ichiro N Maruyama; Atsuko Igari; Yasuo Ikeda; Mitsuru Murata
Journal:  Biochem Biophys Res Commun       Date:  2009-11-26       Impact factor: 3.575

4.  HLA-DRB1*11: a strong risk factor for acquired severe ADAMTS13 deficiency-related idiopathic thrombotic thrombocytopenic purpura in Caucasians.

Authors:  P Coppo; M Busson; A Veyradier; A Wynckel; P Poullin; E Azoulay; L Galicier; P Loiseau
Journal:  J Thromb Haemost       Date:  2010-02-06       Impact factor: 5.824

5.  Multiple B-cell clones producing antibodies directed to the spacer and disintegrin/thrombospondin type-1 repeat 1 (TSP1) of ADAMTS13 in a patient with acquired thrombotic thrombocytopenic purpura.

Authors:  B M Luken; P H P Kaijen; E A M Turenhout; J A Kremer Hovinga; J A van Mourik; R Fijnheer; J Voorberg
Journal:  J Thromb Haemost       Date:  2006-08-08       Impact factor: 5.824

6.  Asymptomatic autoantibodies associate with future anti-glomerular basement membrane disease.

Authors:  Stephen W Olson; Charles B Arbogast; Thomas P Baker; David Owshalimpur; David K Oliver; Kevin C Abbott; Christina M Yuan
Journal:  J Am Soc Nephrol       Date:  2011-08-25       Impact factor: 10.121

7.  Amino acid regions 572-579 and 657-666 of the spacer domain of ADAMTS13 provide a common antigenic core required for binding of antibodies in patients with acquired TTP.

Authors:  Brenda M Luken; Ellen A M Turenhout; Paul H P Kaijen; Mascha J Greuter; Wouter Pos; Jan A van Mourik; Rob Fijnheer; Jan Voorberg
Journal:  Thromb Haemost       Date:  2006-09       Impact factor: 5.249

8.  Natural anti-GBM antibodies from normal human sera recognize alpha3(IV)NC1 restrictively and recognize the same epitopes as anti-GBM antibodies from patients with anti-GBM disease.

Authors:  Rui Yang; Zhao Cui; Thomas Hellmark; Marten Segelmark; Ming-hui Zhao; Hai-yan Wang
Journal:  Clin Immunol       Date:  2007-06-06       Impact factor: 3.969

9.  An autoantibody epitope comprising residues R660, Y661, and Y665 in the ADAMTS13 spacer domain identifies a binding site for the A2 domain of VWF.

Authors:  Wouter Pos; James T B Crawley; Rob Fijnheer; Jan Voorberg; David A Lane; Brenda M Luken
Journal:  Blood       Date:  2009-12-23       Impact factor: 22.113

Review 10.  Unraveling the scissile bond: how ADAMTS13 recognizes and cleaves von Willebrand factor.

Authors:  James T B Crawley; Rens de Groot; Yaozu Xiang; Brenda M Luken; David A Lane
Journal:  Blood       Date:  2011-06-29       Impact factor: 22.113
View more
  12 in total

1.  ADAMTS13 Endopeptidase Protects against Vascular Endothelial Growth Factor Inhibitor-Induced Thrombotic Microangiopathy.

Authors:  Luise Erpenbeck; Melanie Demers; Zsuzsanna K Zsengellér; Maureen Gallant; Stephen M Cifuni; Isaac E Stillman; S Ananth Karumanchi; Denisa D Wagner
Journal:  J Am Soc Nephrol       Date:  2015-06-02       Impact factor: 10.121

2.  ADAMTS13 and von Willebrand factor interactions.

Authors:  Catherine B Zander; Wenjing Cao; X Long Zheng
Journal:  Curr Opin Hematol       Date:  2015-09       Impact factor: 3.284

3.  Weight loss reduces anti-ADAMTS13 autoantibodies and improves inflammatory and coagulative parameters in obese patients.

Authors:  Veronica Zanato; Anna Maria Lombardi; Luca Busetto; Chiara Dal Prà; Mirto Foletto; Luca Prevedello; Giulia Berti De Marinis; Fabrizio Fabris; Roberto Vettor; Roberto Fabris
Journal:  Endocrine       Date:  2016-08-16       Impact factor: 3.633

4.  Phylogenetic and functional analysis of ADAMTS13 identifies highly conserved domains essential for allosteric regulation.

Authors:  Joshua Muia; Jian Zhu; Suellen C Greco; Karen Vanhoorelbeke; Garima Gupta; Lisa A Westfield; J Evan Sadler
Journal:  Blood       Date:  2019-01-30       Impact factor: 22.113

Review 5.  Rituximab therapy in pemphigus and other autoantibody-mediated diseases.

Authors:  Nina A Ran; Aimee S Payne
Journal:  F1000Res       Date:  2017-01-27

Review 6.  Dissecting the pathophysiology of immune thrombotic thrombocytopenic purpura: interplay between genes and environmental triggers.

Authors:  Johana Hrdinová; Silvia D'Angelo; Nuno A G Graça; Bogac Ercig; Karen Vanhoorelbeke; Agnès Veyradier; Jan Voorberg; Paul Coppo
Journal:  Haematologica       Date:  2018-04-19       Impact factor: 9.941

7.  Generation of anti-idiotypic antibodies to detect anti-spacer antibody idiotopes in acute thrombotic thrombocytopenic purpura patients.

Authors:  An-Sofie Schelpe; Elien Roose; Bérangère S Joly; Inge Pareyn; Ilaria Mancini; Marina Biganzoli; Hans Deckmyn; Jan Voorberg; Rob Fijnheer; Flora Peyvandi; Simon F De Meyer; Paul Coppo; Agnès Veyradier; Karen Vanhoorelbeke
Journal:  Haematologica       Date:  2018-12-06       Impact factor: 9.941

Review 8.  Particle-Based Microarrays of Oligonucleotides and Oligopeptides.

Authors:  Alexander Nesterov-Mueller; Frieder Maerkle; Lothar Hahn; Tobias Foertsch; Sebastian Schillo; Valentina Bykovskaya; Martyna Sedlmayr; Laura K Weber; Barbara Ridder; Miriam Soehindrijo; Bastian Muenster; Jakob Striffler; F Ralf Bischoff; Frank Breitling; Felix F Loeffler
Journal:  Microarrays (Basel)       Date:  2014-10-28

9.  Concurrent Presentation of Thrombotic Thrombocytopenic Purpura and Membranous Nephropathy.

Authors:  Laith Al-Rabadi; Karen Quillen; Moshe Shashar; Catreena Al Marji; Aala Jaberi; Vipul Chitalia; Joel Henderson; David Salant; Laurence H Beck
Journal:  Kidney Int Rep       Date:  2017-08-19

Review 10.  ADAMTS-13 and von Willebrand factor: a dynamic duo.

Authors:  K South; D A Lane
Journal:  J Thromb Haemost       Date:  2017-12-02       Impact factor: 5.824
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.